Research
Showing of 189 results
Oxford-Harrington Rare Disease Centre Announces 2025 Scholars Advancing Promising Treatments
Ten scientists selected for second annual award to pursue innovations in gene, RNA, small molecule and cell therapies to treat rare and ultra-rare diseases.
Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
Positive results of zalunfiban announced at AHA Scientific Sessions.
University Hospitals Seidman Cancer Center Researchers Find Age Should Be a Consideration in Metastatic Prostate Cancer Treatment Plans
The study, published in the October 28, 2025 edition of New England Journal of Medicine Evidence, was led by senior author Daniel Spratt, MD.
Randomized Clinical Trial Led by University Hospitals Seidman Cancer Center Oncologist Leads to Practice-Changing Precision Prostate Cancer Therapy
Randomized trial validates first biomarker tool to guide hormone treatment decisions, allowing for more personalized prostate cancer care.
Transformative Eye Research Expands Donor Pool for Corneal Transplant Patients
Study shows corneas from donors with diabetes are just as effective for surgery.
Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2026 Harrington-MSTP Scholar Award
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines.
Oxford-Harrington Rare Disease Centre Announces David Cameron, Chair of its Advisory Council, as a Guest Speaker at Morgan Stanley Exchange 2025
In ‘A Conversation on Courage,’ Lord Cameron and Morgan Stanley’s Andy Saperstein discussed philanthropy as a catalyst for rare disease innovation.
University Hospitals Receives a $2.3 Million Grant from the John Templeton Foundation
The grant will support the project titled “Transforming Healthcare through the Power of Love: Expanding and Spreading the 'Living and Leading with Love' Framework”